{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:00:21Z","timestamp":1770505221557,"version":"3.49.0"},"reference-count":41,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2012]]},"DOI":"10.1248\/bpb.35.677","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T06:45:14Z","timestamp":1337841914000},"page":"677-685","source":"Crossref","is-referenced-by-count":5,"title":["Establishment of a Stable Human Cell Line, HPL-A3, for Use in Reporter Gene Assays of Cytochrome P450 3A Inducers"],"prefix":"10.1248","volume":"35","author":[{"given":"Masashi","family":"Sekimoto","sequence":"first","affiliation":[{"name":"Department of Molecular Toxicology and Global Center of Excellence Program, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Molecular Toxicology and Global Center of Excellence Program, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuomi","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Department of Molecular Toxicology and Global Center of Excellence Program, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyomitsu","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Toxicology and Global Center of Excellence Program, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakuni","family":"Degawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Toxicology and Global Center of Excellence Program, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr. Drug Metab.<\/i>, 3<\/b>, 561–597 (2002)."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.2174\/138920008784220664"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tachibana T, Kato M, Takano J, Sugiyama Y. Predicting drug–drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein. Curr. Drug Metab.<\/i>, 11<\/b>, 762–777 (2010).","DOI":"10.2174\/138920010794328922"},{"key":"4","unstructured":"4) Donato MT, Lahoz A, Castell JV, Gómez-Lechón MJ. Cell lines: a tool for in vitro<\/i> drug metabolism studies. Curr. Drug Metab.<\/i>, 9<\/b>, 1–11 (2008)."},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.006759"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterström RH, Perlmann T, Lehmann JM. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell<\/i>, 92<\/b>, 73–82 (1998).","DOI":"10.1016\/S0092-8674(00)80900-9"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3703"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J. Biol. Chem.<\/i>, 277<\/b>, 25125–25132 (2002).","DOI":"10.1074\/jbc.M201323200"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001215200"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Han S, Chiang JYL. Mechanism of vitamin D receptor inhibition of cholesterol 7α-hydroxylase gene transcription in human hepatocytes. Drug Metab. Dispos.<\/i>, 37<\/b>, 469–478 (2009).","DOI":"10.1124\/dmd.108.025155"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.038653"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.07.041"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.001594"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfj173"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.21.99"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol. Pharmacol.<\/i>, 56<\/b>, 1329–1339 (1999).","DOI":"10.1124\/mol.56.6.1329"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1248\/jhs.50.530"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.3123\/jemsge.29.11"},{"key":"19","unstructured":"19) Dotzlaw H, Leygue E, Watson P, Murphy LC. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin. Cancer Res.<\/i>, 5<\/b>, 2103–2107 (1999)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Malaplate-Armand C, Ferrari L, Masson C, Visvikis-Siest S, Lambert H, Batt AM. Down-regulation of astroglial CYP2C, glucocorticoid receptor and constitutive androstane receptor genes in response to cocaine in human U373 MG astrocytoma cells. Toxicol. Lett.<\/i>, 159<\/b>, 203–211 (2005).","DOI":"10.1016\/j.toxlet.2005.04.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Matsubara T, Yoshinari K, Aoyama K, Sugawara M, Sekiya Y, Nagata K, Yamazoe Y. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro<\/i> and in vivo<\/i>. Drug Metab. Dispos.<\/i>, 36<\/b>, 2058–2063 (2008).","DOI":"10.1124\/dmd.108.021501"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb03238.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Zhuo X, Zheng N, Felix CA, Blair IA. Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab. Dispos.<\/i>, 32<\/b>, 993–1000 (2004).","DOI":"10.1016\/S0090-9556(24)02983-0"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2.4.629"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1210\/me.14.1.27"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(01)00163-6"},{"key":"27","unstructured":"27) Drocourt L, Pascussi JM, Assenat E, Fabre JM, Maurel P, Vilarem MJ. Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes. Drug Metab. Dispos.<\/i>, 29<\/b>, 1325–1331 (2001)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Vignati LA, Bogni A, Grossi P, Monshouwer M. A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction. Toxicology<\/i>, 199<\/b>, 23–33 (2004).","DOI":"10.1016\/j.tox.2003.12.018"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sane RS, Buckley DJ, Buckley AR, Nallani SC, Desai PB. Role of human pregnane X receptor in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary human hepatocytes and LS174T cells. Drug Metab. Dispos.<\/i>, 36<\/b>, 946–954 (2008).","DOI":"10.1124\/dmd.107.018598"},{"key":"30","unstructured":"30) Cui X, Thomas A, Gerlach V, White RE, Morrison RA, Cheng KC. Application and interpretation of hPXR screening data: Validation of reporter signal requirements for prediction of clinically relevant CYP3A4 inducers. Biochem. Pharmacol.<\/i>, 76<\/b>, 680–689 (2008)."},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1080\/0049825021000023987"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2003.12.009"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1080\/00498250412331285472"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199325060-00005"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto_157.x"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.27.903"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38) Pan Y, Li L, Kim G, Ekins S, Wang H, Swaan PW. Identification and validation of novel human pregnane X receptor activators among prescribed drugs via<\/i> ligand-based virtual screening. Drug Metab. Dispos.<\/i>, 39<\/b>, 337–344 (2011).","DOI":"10.1124\/dmd.110.035808"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39) Shukla SJ, Sakamuru S, Huang R, Moeller TA, Shinn P, Vanleer D, Auld DS, Austin CP, Xia M. Identification of clinically used drugs that activate pregnane X receptors. Drug Metab. Dispos.<\/i>, 39<\/b>, 151–159 (2011).","DOI":"10.1124\/dmd.110.035105"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40) Xiao L, Nickbarg E, Wang W, Thomas A, Ziebell M, Prosise WW, Lesburg CA, Taremi SS, Gerlach VL, Le HV, Cheng KC. Evaluation of in vitro<\/i> PXR-based assays and in silico<\/i> modeling approaches for understanding the binding of a structurally diverse set of drugs to PXR. Biochem. Pharmacol.<\/i>, 81<\/b>, 669–679 (2011).","DOI":"10.1016\/j.bcp.2010.12.003"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.19.135"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42) Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell<\/i>, 126<\/b>, 789–799 (2006).","DOI":"10.1016\/j.cell.2006.06.049"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/35\/5\/35_5_677\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T18:42:43Z","timestamp":1743187363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/35\/5\/35_5_677\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.35.677","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}